Search Results for: isct

Stem cell & regenerative medicine meetings for you to go to in 2019

Stem-Cell-Meetings-2019

I keep a yearly hub of stem cell & regenerative medicine meetings here on The Niche. Below I’ve pasted the list for 2019, which continues to grow. If you don’t see yours listed, send me an email with the info including a link (knoepflerATucdavisDOTedu). These meeting listings are not endorsements and I try to make

Stem cell & regenerative medicine meetings for you to go to in 2019 Read More »

Stem cell news update: the good, the bad, & the weird

embryo-model-legos-1

With stem cells there’s always all kinds of developments and news every week or even every day. Here is an assortment in no particular order of some of the latest news including some across the spectrum including weird and sometimes stuff. The linked phrases are often the actual headlines of the media pieces. New CIRM

Stem cell news update: the good, the bad, & the weird Read More »

List of regenerative medicine & stem cell meetings for rest of 2018

Stem-cell-meetings-2018

This post contains a list of the remaining regenerative medicine and stem cell meetings for 2018. If you are interested in history, here’s our first ever meetings list for way back in 2012. Here’s the 2018 list. 10th World Congress and Expo on Cell & Stem Cell Research, NY, NY USA, March 19-21, 2018. iPSCs: A

List of regenerative medicine & stem cell meetings for rest of 2018 Read More »

Cynata stem cell trial update: CEO Ross Macdonald interview

Koch-et-al_2016_MCA-derived-MSC-Treatment-of-Hindlimb-Ischemia-in-Mice-e1498668676851

Stem cell clinical trials have a certain gravitational pull for me as I’m always fascinated by them and since the new Cynata trial is moving forward, I recently did an interview their CEO, Dr. Ross A. Macdonald to find out more. PK: Cynata’s recently initiated clinical trial aims to treat GVHD as have other stem

Cynata stem cell trial update: CEO Ross Macdonald interview Read More »

Blogging today’s FDA stem cell meeting: Part 2 Clinics, Policy & Ethics

Jonathan-Kimmelman-FDA-e1473490111453

The FDA is holding its first 2016 stem cell meeting today and you can read about some impressions of the morning session of this meeting here. In this post, I’m focusing on the afternoon session, which has been mostly on policy and ethics, including on stem cell clinics. Jonathan Kimmelman from McGill University got the afternoon going

Blogging today’s FDA stem cell meeting: Part 2 Clinics, Policy & Ethics Read More »